Molecular profile
- Sequence
- Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula
- C 78 H 125 N 23 O 23 S 2
- Molecular Weight
- 1817.12 g/mol
- CAS Number
- 66004-57-7
Peptide research profile
hGH Fragment 176-191
HGH Fragment 176-191 is a synthetic fragment derived from natural human growth hormone (hGH). Commonly known as the “lipolytic fragment,” it is renowned for its capacity to enhance fat reduction. This compound has demonstrated its effectiveness in reducing blood sugar levels and supporting the healing of cartilage.…
Dosing literacy
Dosing & scaling, explained
The moderated mass amounts below are retained for comparison. Near-duplicates, mix-dependent volumes and device markings are excluded. This is educational source context—not a protocol or recommendation.
Recorded amount context
Mass amounts available for comparison
- Lower range0.5 mgWeeks 1–4
Recorded example with no verified study backing; shown for amount literacy only.
- Mid range10 mgWeeks 5–15
Recorded example with no verified study backing; shown for amount literacy only.
Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.
Schedule literacy
No independently verified schedule
Evidence context
No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.
Research best practices
Storage, handling and interpretation
Product identity
Verify the exact compound, formulation and amount against the product label or certificate before calculation.
Storage & handling
Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.
Prepared solutions
Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.
Research orientation
What researchers are exploring
These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.
- 01
Research Focus
Key findings in metabolic regulation and energy balance
- 02
Future Directions
Emerging areas of exploration and translational potential
Evidence map
What is known—and what still needs verification
Available context is organized without assigning unsupported study models or evidence grades.
- Source review pending
Research Focus
Key findings in metabolic regulation and energy balance
- Source review pending
Future Directions
Emerging areas of exploration and translational potential
Recorded protocol library
Amounts recorded for hGH Fragment 176-191
These amount records are independent from vial strength, reconstitution volume and measuring device. A recorded source is not the same as study backing, and these values are not recommendations.
- 01
Weeks 1–4
0.5 mg
Sign in for schedule, duration and source context.
- 02
Weeks 5–15 · upper endpoint
10 mg
Sign in for schedule, duration and source context.
Technical reference
Identity, limitations and unknowns
Important limitations
- Safety Profile: Clinical observations and risk mitigation insights
Source review
1 links awaiting verification
- Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending